thiophenes has been researched along with Macular Edema in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.50) | 18.2507 |
| 2000's | 4 (10.00) | 29.6817 |
| 2010's | 28 (70.00) | 24.3611 |
| 2020's | 7 (17.50) | 2.80 |
| Authors | Studies |
|---|---|
| Figueiredo, R; Garrido, J; Morais Sarmento, T; Ramalho, A | 1 |
| Abrams, G; Adolfsson, E; Agarwal, PK; Akkan, AG; Al Alhareth, NS; Alves, VGL; Armentano, R; Bahroos, E; Baig, M; Baldridge, KK; Barman, S; Bartolucci, C; Basit, A; Bertoli, SV; Bian, L; Bigatti, G; Bobenko, AI; Boix, PP; Bokulic, T; Bolink, HJ; Borowiec, J; Bulski, W; Burciaga, J; Butt, NS; Cai, AL; Campos, AM; Cao, G; Cao, Y; Čapo, I; Caruso, ML; Chao, CT; Cheatum, CM; Chelminski, K; Chen, AJW; Chen, C; Chen, CH; Chen, D; Chen, G; Chen, H; Chen, LH; Chen, R; Chen, RX; Chen, X; Cherdtrakulkiat, R; Chirvony, VS; Cho, JG; Chu, K; Ciurlino, D; Coletta, S; Contaldo, G; Crispi, F; Cui, JF; D'Esposito, M; de Biase, S; Demir, B; Deng, W; Deng, Z; Di Pinto, F; Domenech-Ximenos, B; Dong, G; Drácz, L; Du, XJ; Duan, LJ; Duan, Y; Ekendahl, D; Fan, W; Fang, L; Feng, C; Followill, DS; Foreman, SC; Fortunato, G; Frew, R; Fu, M; Gaál, V; Ganzevoort, W; Gao, DM; Gao, X; Gao, ZW; Garcia-Alvarez, A; Garza, MS; Gauthier, L; Gazzaz, ZJ; Ge, RS; Geng, Y; Genovesi, S; Geoffroy, V; Georg, D; Gigli, GL; Gong, J; Gong, Q; Groeneveld, J; Guerra, V; Guo, Q; Guo, X; Güttinger, R; Guyo, U; Haldar, J; Han, DS; Han, S; Hao, W; Hayman, A; He, D; Heidari, A; Heller, S; Ho, CT; Ho, SL; Hong, SN; Hou, YJ; Hu, D; Hu, X; Hu, ZY; Huang, JW; Huang, KC; Huang, Q; Huang, T; Hwang, JK; Izewska, J; Jablonski, CL; Jameel, T; Jeong, HK; Ji, J; Jia, Z; Jiang, W; Jiang, Y; Kalumpha, M; Kang, JH; Kazantsev, P; Kazemier, BM; Kebede, B; Khan, SA; Kiss, J; Kohen, A; Kolbenheyer, E; Konai, MM; Koniarova, I; Kornblith, E; Krawetz, RJ; Kreouzis, T; Kry, SF; Laepple, T; Lalošević, D; Lan, Y; Lawung, R; Lechner, W; Lee, KH; Lee, YH; Leonard, C; Li, C; Li, CF; Li, CM; Li, F; Li, J; Li, L; Li, S; Li, X; Li, Y; Li, YB; Li, Z; Liang, C; Lin, J; Lin, XH; Ling, M; Link, TM; Liu, HH; Liu, J; Liu, M; Liu, W; Liu, YP; Lou, H; Lu, G; Lu, M; Lun, SM; Ma, Z; Mackensen, A; Majumdar, S; Martineau, C; Martínez-Pastor, JP; McQuaid, JR; Mehrabian, H; Meng, Y; Miao, T; Miljković, D; Mo, J; Mohamed, HSH; Mohtadi, M; Mol, BWJ; Moosavi, L; Mosdósi, B; Nabu, S; Nava, E; Ni, L; Novakovic-Agopian, T; Nyamunda, BC; Nyul, Z; Önal, B; Özen, D; Özyazgan, S; Pajkrt, E; Palazon, F; Park, HW; Patai, Á; Patai, ÁV; Patzke, GR; Payette, G; Pedoia, V; Peelen, MJCS; Pellitteri, G; Peng, J; Perea, RJ; Pérez-Del-Rey, D; Popović, DJ; Popović, JK; Popović, KJ; Posecion, L; Povall, J; Prachayasittikul, S; Prachayasittikul, V; Prat-González, S; Qi, B; Qu, B; Rakshit, S; Ravelli, ACJ; Ren, ZG; Rivera, SM; Salo, P; Samaddar, S; Samper, JLA; Samy El Gendy, NM; Schmitt, N; Sekerbayev, KS; Sepúlveda-Martínez, Á; Sessolo, M; Severi, S; Sha, Y; Shen, FF; Shen, X; Shen, Y; Singh, P; Sinthupoom, N; Siri, S; Sitges, M; Slovak, JE; Solymosi, N; Song, H; Song, J; Song, M; Spingler, B; Stewart, I; Su, BL; Su, JF; Suming, L; Sun, JX; Tantimavanich, S; Tashkandi, JM; Taurbayev, TI; Tedgren, AC; Tenhunen, M; Thwaites, DI; Tibrewala, R; Tomsejm, M; Triana, CA; Vakira, FM; Valdez, M; Valente, M; Valentini, AM; Van de Winckel, A; van der Lee, R; Varga, F; Varga, M; Villarino, NF; Villemur, R; Vinatha, SP; Vincenti, A; Voskamp, BJ; Wang, B; Wang, C; Wang, H; Wang, HT; Wang, J; Wang, M; Wang, N; Wang, NC; Wang, Q; Wang, S; Wang, X; Wang, Y; Wang, Z; Wen, N; Wesolowska, P; Willis, M; Wu, C; Wu, D; Wu, L; Wu, X; Wu, Z; Xia, JM; Xia, X; Xia, Y; Xiao, J; Xiao, Y; Xie, CL; Xie, LM; Xie, S; Xing, Z; Xu, C; Xu, J; Yan, D; Yan, K; Yang, S; Yang, X; Yang, XW; Ye, M; Yin, Z; Yoon, N; Yoon, Y; Yu, H; Yu, K; Yu, ZY; Zhang, B; Zhang, GY; Zhang, H; Zhang, J; Zhang, M; Zhang, Q; Zhang, S; Zhang, W; Zhang, X; Zhang, Y; Zhang, YW; Zhang, Z; Zhao, D; Zhao, F; Zhao, P; Zhao, W; Zhao, Z; Zheng, C; Zhi, D; Zhou, C; Zhou, FY; Zhu, D; Zhu, J; Zhu, Q; Zinyama, NP; Zou, M; Zou, Z | 1 |
| Fazel, F; Nikpour, H; Pourazizi, M | 1 |
| Chen, E; Chiang, A; Garg, SJ; Ho, AC; Hsu, J; Jenkins, TL; Mikhail, M; Obeid, A; Patel, SN; Shah, CP; Spirn, MJ; Vander, JF; Wibbelsman, TD; Wolfe, JD | 1 |
| Fujiwara, K; Funatsu, J; Ikeda, Y; Murakami, Y; Nakatake, S; Shimokawa, S; Sonoda, KH; Yoshida, N | 1 |
| Kamiya, T; Kinouchi, R; Otsubo, M; Yoshida, A | 1 |
| Akiyama, M; Fujiwara, K; Funatsu, J; Ikeda, Y; Koyanagi, Y; Murakami, Y; Nakatake, S; Shimokawa, S; Sonoda, KH; Takeda, A; Yoshida, N | 1 |
| Chen, R; Huang, Q; Lin, X; Xiang, Z | 1 |
| Conrath, J; Donnadieu, B; Fakhoury, O; Matonti, F; Warrak, R | 1 |
| Hirji, N; Kalitzeos, A; Michaelides, M; Quartilho, A; Strong, SA | 1 |
| Kim, DG; Kim, HW; Lee, SJ; Yoon, CK | 1 |
| Chiang, A; Ehmann, D; Gao, X; Ho, AC; Hsu, J; Obeid, A; Park, CH; Sridhar, J | 1 |
| Ghasempour, M; Khojasteh, H; Riazi-Esfahani, H; Roohipoor, R | 1 |
| Enaida, H; Hisatomi, T; Ikeda, Y; Ishibashi, T; Murakami, Y; Notomi, S; Yoshida, N | 2 |
| Baser, EF; Gülhan, C; Öztürk, B; Seymenoğlu, G | 1 |
| Alisan, S; Onder, HI; Tunc, M | 1 |
| Brodie, SE; Capasso, JE; Cordovez, JA; Ganesh, A; Levin, AV; Neely, KA; Rychwalski, PJ; Sadagopan, KA; Traboulsi, EI | 1 |
| Finzi, S; Sundin, O; Susanna, BN; Susanna, R; Takahashi, WY; Zacharias, LC | 1 |
| Brandão, EM; Estrela Silva, SE; Falcão-Reis, FM; Lemos Reis, RF; Moreira-Gonçalves, N | 1 |
| Liew, G; Michaelides, M; Moore, AT; Webster, AR | 1 |
| Applegate, CD; Han, IC; Scholl, HP; Strauss, RW; Wolfson, Y | 1 |
| Farmand, G; Fiebig, B; Kellner, S; Kellner, U; Stöhr, H; Weber, BH; Weinitz, S | 1 |
| Bjeloš, M; Bosnar, D; Bušić, I; Bušić, M; Ramić, S | 1 |
| Abelairas-Gómez, J; Bravo-Ljubetic, L; Larrañaga-Fragoso, P; Pastora, N; Peralta, J | 1 |
| Al Khayat, A; Al Shekaili, H; Al Zuhaibi, S; Al-Hosni, A; Capasso, J; Cater, JR; Ganesh, A; Karthikeyan, AS; Levin, AV; Lingao, MD; Stroh, E; Trumler, AA | 1 |
| Andrew, NH; Hassall, MM | 1 |
| Byeon, SH; Kim, SE; Kwon, OW; Park, YS; Song, JH | 1 |
| Fishman, GA; Genead, MA; Walia, S | 1 |
| Arroyo, JG; Cohen, SM; Lujan, BJ; Reichel, E | 1 |
| Fishman, GA; Genead, MA | 1 |
| Fishman, GA; Genead, MA; McAnany, JJ | 2 |
| Fishman, GA; Thobani, A | 1 |
| Ehlers, JP; Rayess, H; Steinle, N | 1 |
| Kiszkielis, M; Lubiński, W; Penkala, K | 1 |
| Apushkin, MA; Fishman, GA; Grover, S | 1 |
| Giuffre, G | 1 |
| Apushkin, MA; Fishman, GA | 1 |
| Adelman, AE; Fiscella, RG; Fishman, GA; Grover, S | 1 |
2 review(s) available for thiophenes and Macular Edema
| Article | Year |
|---|---|
Topics: Acetylcholine; Acinetobacter baumannii; Actinobacteria; Action Potentials; Adalimumab; Adaptation, Physiological; Adipates; Administration, Oral; Adolescent; Adrenal Glands; Adsorption; Adult; Aged; Aged, 80 and over; Aging; AIDS-Related Opportunistic Infections; Aldosterone; Amino Acids; Ammonia; Amoxicillin; AMP-Activated Protein Kinases; Animals; Antacids; Anti-Bacterial Agents; Antineoplastic Agents; Antirheumatic Agents; Apgar Score; Area Under Curve; ARNTL Transcription Factors; Arterial Pressure; Arthritis, Juvenile; Athletes; Attention; Biodegradation, Environmental; Biofilms; Biofuels; Biological Therapy; Biomass; Biomimetic Materials; Bioreactors; Birth Weight; Bismuth; Blood Flow Velocity; Bone and Bones; Brain Injuries, Traumatic; Calcium; Calcium Channels; Capsaicin; Carbon; Carcinoma, Hepatocellular; Cardiomegaly, Exercise-Induced; Cartilage; Cartilage, Articular; Case-Control Studies; Catalysis; Cats; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Death; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Charcoal; Chemokine CCL2; Child; Child, Preschool; Chondrogenesis; Chronic Disease; Circadian Clocks; Circadian Rhythm Signaling Peptides and Proteins; Clarithromycin; Coccidioides; Coccidioidomycosis; Cognitive Behavioral Therapy; Coinfection; Color; Coloring Agents; Computer Simulation; Computers, Molecular; Consensus; Corticosterone; Cyclic AMP Response Element-Binding Protein; Cytochrome P-450 Enzyme System; Death, Sudden, Cardiac; Density Functional Theory; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Dialysis Solutions; Disease Models, Animal; Dogs; Dopamine Agonists; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Electrocardiography; Electrocardiography, Ambulatory; Electrolytes; Endocardium; Endocrine Disruptors; Endocytosis; Endoscopy, Gastrointestinal; Escherichia coli Proteins; Esters; Evolution, Molecular; Executive Function; Feasibility Studies; Female; Ferric Compounds; Fluorescence; Fluorescent Dyes; Fluorine Radioisotopes; Frailty; Free Radical Scavengers; Gabapentin; Geriatric Assessment; Glucaric Acid; Glucocorticoids; Glucose; Glucose Metabolism Disorders; Halogenated Diphenyl Ethers; Heart Rate; Heart Ventricles; HEK293 Cells; Helicobacter Infections; Helicobacter pylori; Hep G2 Cells; Hepatocytes; Humans; Hungary; Hydrogen Sulfide; Hydrogen-Ion Concentration; Immunologic Factors; Immunomodulation; Immunosuppressive Agents; Independent Living; Indocyanine Green; Infant; Infant Formula; Infant Mortality; Infant, Newborn; Infant, Newborn, Diseases; Inflorescence; Insulin Resistance; Insulins; International Agencies; Iron; Isotonic Solutions; Kidney Failure, Chronic; Kinetics; Lactones; Leukocytes, Mononuclear; Liver Neoplasms; Macular Edema; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetosomes; Male; Medical Audit; Mesenchymal Stem Cells; Metabolic Syndrome; Metformin; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Middle Aged; Molecular Conformation; Molecular Targeted Therapy; Motor Activity; Multiple Sclerosis; Mycophenolic Acid; Netherlands; Neuropsychological Tests; Nuclear Energy; Organs at Risk; Osteoarthritis; Osteoarthritis, Hip; Oxidation-Reduction; Palladium; Pericardium; Perinatal Death; Peritoneal Dialysis; Phantoms, Imaging; Pharmaceutical Preparations; Phospholipids; Phosphorylation; Physical Conditioning, Human; Physical Endurance; Pilot Projects; Polyketides; Polymers; Positron-Emission Tomography; Postoperative Period; Potassium; Powders; Pramipexole; Predictive Value of Tests; Pregabalin; Pregnancy; Pregnancy Outcome; Protein Structure, Secondary; Proton Pump Inhibitors; Puberty; Pulmonary Circulation; Quality Assurance, Health Care; Quantum Dots; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Rats, Sprague-Dawley; Receptors, CCR2; Receptors, Transferrin; Regeneration; Registries; Renal Insufficiency, Chronic; Reproducibility of Results; Research Design; Restless Legs Syndrome; Retina; Retinoid X Receptor alpha; Retrospective Studies; Rhenium; Risk Factors; RNA, Messenger; Severity of Illness Index; Sex Factors; Sodium; Sodium Fluoride; Solvents; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Stereoisomerism; Stroke; Structure-Activity Relationship; Tachycardia, Ventricular; Tetracycline; Tetrahydrofolate Dehydrogenase; Tetrahydronaphthalenes; Thermodynamics; Thiophenes; Time Factors; Tinidazole; Tomography, Optical Coherence; Tomography, X-Ray Computed; Topiramate; Toxoplasma; Toxoplasmosis, Cerebral; Transferrin; Treatment Outcome; Up-Regulation; Upper Extremity; Uremia; Uveitis; Vascular Remodeling; Ventricular Fibrillation; Ventricular Function, Left; Ventricular Function, Right; Ventricular Remodeling; Verapamil; Veterans; Visual Acuity; Vitrectomy; Water Pollutants, Chemical; Zea mays; Zirconium | 2019 |
Efficacy of carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa: A meta-analysis.
Topics: Acetazolamide; Administration, Oral; Administration, Topical; Carbonic Anhydrase Inhibitors; Clinical Trials as Topic; Female; Humans; Macular Edema; Male; Prospective Studies; Retinitis Pigmentosa; Sulfonamides; Thiophenes; Treatment Outcome; Visual Acuity | 2017 |
8 trial(s) available for thiophenes and Macular Edema
| Article | Year |
|---|---|
Combination of Intravitreal Bevacizumab and Topical Dorzolamide versus Intravitreal Bevacizumab Alone for Diabetic Macular Edema: A Randomized Contralateral Clinical Trial.
Topics: Administration, Topical; Aged; Bevacizumab; Diabetic Retinopathy; Female; Humans; Intravitreal Injections; Iran; Macular Edema; Male; Middle Aged; Sulfonamides; Thiophenes | 2020 |
Effect of Adjuvant Topical Dorzolamide-Timolol vs Placebo in Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial.
Topics: Administration, Ophthalmic; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Chemotherapy, Adjuvant; Choroidal Neovascularization; Drug Combinations; Exudates and Transudates; Female; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Ophthalmic Solutions; Placebos; Single-Blind Method; Sulfonamides; Thiophenes; Timolol; Tomography, Optical Coherence; Visual Acuity; Wet Macular Degeneration | 2020 |
Comparison of dorzolamide/timolol versus brimonidine/timolol fixed combination therapy in the management of steroid-induced ocular hypertension.
Topics: Aged; Antihypertensive Agents; Brimonidine Tartrate; Diabetic Retinopathy; Drug Combinations; Female; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Quinoxalines; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular; Triamcinolone Acetonide | 2015 |
Comparison of topical dorzolamide and ketorolac treatment for cystoid macular edema in retinitis pigmentosa and Usher's syndrome.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Carbonic Anhydrase Inhibitors; Female; Fovea Centralis; Humans; Ketorolac Tromethamine; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Retinitis Pigmentosa; Sulfonamides; Thiophenes; Tomography, Optical Coherence; Usher Syndromes; Visual Acuity; Visual Field Tests; Visual Fields; Young Adult | 2015 |
Prolongation of activity of single intravitreal bevacizumab by adjuvant topical aqueous depressant (Timolol-Dorzolamide).
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antihypertensive Agents; Aqueous Humor; Bevacizumab; Diabetic Retinopathy; Drug Synergism; Drug Therapy, Combination; Female; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Sulfonamides; Thiophenes; Timolol; Treatment Outcome; Visual Acuity; Vitreous Body | 2009 |
Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa.
Topics: Administration, Topical; Adolescent; Adult; Carbonic Anhydrase Inhibitors; Diagnostic Techniques, Ophthalmological; Female; Humans; Macular Edema; Male; Middle Aged; Prospective Studies; Retinitis Pigmentosa; Sulfonamides; Thiophenes; Tomography, Optical Coherence; Visual Acuity | 2006 |
Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa.
Topics: Carbonic Anhydrase Inhibitors; Drug Administration Schedule; Follow-Up Studies; Fovea Centralis; Humans; Macular Edema; Prospective Studies; Retinitis Pigmentosa; Sulfonamides; Thiophenes; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2007 |
Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa.
Topics: Acetazolamide; Administration, Oral; Administration, Topical; Adolescent; Adult; Aged; Carbonic Anhydrase Inhibitors; Chronic Disease; Cross-Over Studies; Double-Blind Method; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Retinitis Pigmentosa; Sulfonamides; Thiophenes; Visual Acuity | 1997 |
30 other study(ies) available for thiophenes and Macular Edema
| Article | Year |
|---|---|
Pigmented paravenous retinochoroidal atrophy associated with unilateral cystoid macular oedema.
Topics: Aged; Angiogenesis Inhibitors; Bevacizumab; Carbonic Anhydrase Inhibitors; Eye Diseases, Hereditary; Fluorescein Angiography; Humans; Injections, Intraocular; Macular Edema; Male; Retinal Degeneration; Sulfonamides; Thiophenes; Tomography, Optical Coherence | 2019 |
Effect of Topical Dorzolamide on Cystoid Macular Edema in Retinitis Pigmentosa.
Topics: Carbonic Anhydrase Inhibitors; Dose-Response Relationship, Drug; Female; Humans; Macula Lutea; Macular Edema; Male; Ophthalmic Solutions; Retinitis Pigmentosa; Retrospective Studies; Sulfonamides; Thiophenes; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2020 |
Regression of taxane-related cystoid macular edema after topical dorzolamide treatment: two case reports.
Topics: Aged; Female; Humans; Macular Edema; Male; Quality of Life; Sulfonamides; Taxoids; Thiophenes; Tomography, Optical Coherence | 2021 |
RECURRENCE RATE OF CYSTOID MACULAR EDEMA WITH TOPICAL DORZOLAMIDE TREATMENT AND ITS RISK FACTORS IN RETINITIS PIGMENTOSA.
Topics: Administration, Topical; Carbonic Anhydrase Inhibitors; Female; Follow-Up Studies; Humans; Incidence; Japan; Macula Lutea; Macular Edema; Male; Middle Aged; Prospective Studies; Recurrence; Retinitis Pigmentosa; Risk Assessment; Risk Factors; Sulfonamides; Thiophenes; Time Factors; Tomography, Optical Coherence; Visual Acuity | 2022 |
Treatment of cystoid macular edema in homozygous twins with glutathione synthetase deficiency and retinal dystrophy.
Topics: Acetazolamide; Administration, Oral; Amino Acid Metabolism, Inborn Errors; Child; Combined Modality Therapy; Diseases in Twins; Drug Therapy, Combination; Glutathione Synthase; Humans; Macular Edema; Male; Ophthalmic Solutions; Retinal Dystrophies; Sulfonamides; Thiophenes | 2018 |
Retrospective cohort study exploring whether an association exists between spatial distribution of cystoid spaces in cystoid macular oedema secondary to retinitis pigmentosa and response to treatment with carbonic anhydrase inhibitors.
Topics: Acetazolamide; Adolescent; Adult; Aged; Carbonic Anhydrase Inhibitors; Female; Humans; Macular Edema; Male; Middle Aged; Retinitis Pigmentosa; Retrospective Studies; Sulfonamides; Thiazines; Thiophenes; Tomography, Optical Coherence; Visual Acuity; Visual Field Tests; Young Adult | 2019 |
Effect of topical dorzolamide therapy on cystoid macular edema in hydroxychloroquine retinopathy.
Topics: Administration, Topical; Adult; Aged; Antirheumatic Agents; Carbonic Anhydrase Inhibitors; Female; Fluorescein Angiography; Fundus Oculi; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Macular Edema; Retinal Diseases; Sulfonamides; Thiophenes; Visual Acuity | 2018 |
TOPICAL DORZOLAMIDE-TIMOLOL WITH INTRAVITREOUS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR RETINAL VEIN OCCLUSION: A PILOT STUDY.
Topics: Administration, Ophthalmic; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Drug Combinations; Drug Therapy, Combination; Female; Fovea Centralis; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Pilot Projects; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retinal Vein Occlusion; Sulfonamides; Thiophenes; Timolol; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity | 2021 |
TOPICAL DORZOLAMIDE FOR CYSTOID MACULAR EDEMA IN BIETTI CRYSTALLINE RETINAL DYSTROPHY.
Topics: Administration, Ophthalmic; Adult; Carbonic Anhydrase Inhibitors; Corneal Dystrophies, Hereditary; Female; Humans; Macular Edema; Multimodal Imaging; Ophthalmic Solutions; Retinal Diseases; Sulfonamides; Thiophenes; Visual Acuity | 2021 |
Therapeutic effect of prolonged treatment with topical dorzolamide for cystoid macular oedema in patients with retinitis pigmentosa.
Topics: Administration, Topical; Adult; Antihypertensive Agents; Carbonic Anhydrase Inhibitors; Female; Humans; Macular Edema; Male; Middle Aged; Prospective Studies; Retinitis Pigmentosa; Sulfonamides; Thiophenes; Time Factors; Tomography, Optical Coherence; Young Adult | 2013 |
Serous retinal detachment and cystoid macular edema in a patient with Wyburn-Mason syndrome.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Arteriovenous Fistula; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Ketorolac Tromethamine; Macular Edema; Magnetic Resonance Imaging; Male; Neurocutaneous Syndromes; Prednisolone; Retinal Detachment; Subretinal Fluid; Sulfonamides; Thiophenes; Tomography, Optical Coherence; Triamcinolone Acetonide | 2015 |
Retinal Dystrophy with Intraretinal Cystoid Spaces Associated with Mutations in the Crumbs Homologue (CRB1) Gene.
Topics: Acetazolamide; Adolescent; Carbonic Anhydrase Inhibitors; Child; Child, Preschool; Eye Proteins; Female; Humans; Macular Edema; Male; Membrane Proteins; Mutation; Nerve Tissue Proteins; Pedigree; Polymerase Chain Reaction; Retinal Dystrophies; Retrospective Studies; Sulfonamides; Thiophenes; Tomography, Optical Coherence; Visual Acuity | 2015 |
Efficacy of topical dorzolamide therapy for cystoid macular edema in a patient with MFRP-related nanophthalmos-retinitis pigmentosa-foveoschisis-optic disk drusen syndrome.
Topics: Administration, Topical; Carbonic Anhydrase Inhibitors; Female; Frameshift Mutation; Humans; Macular Edema; Membrane Proteins; Microphthalmos; Middle Aged; Optic Disk Drusen; Retinitis Pigmentosa; Sulfonamides; Syndrome; Thiophenes; Treatment Outcome | 2015 |
Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa.
Topics: Acetazolamide; Administration, Oral; Adult; Carbonic Anhydrase Inhibitors; Cohort Studies; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Retinitis Pigmentosa; Retrospective Studies; Sulfonamides; Thiophenes; Tomography, Optical Coherence; Treatment Outcome | 2015 |
CRB1-Related Maculopathy With Cystoid Macular Edema.
Topics: Administration, Topical; Carbonic Anhydrase Inhibitors; Child; Diseases in Twins; DNA Mutational Analysis; Electroretinography; Eye Proteins; Female; Fluorescein Angiography; Humans; Macular Edema; Membrane Proteins; Mutation; Nerve Tissue Proteins; Ophthalmic Solutions; Retinal Dystrophies; Sulfonamides; Thiophenes; Tomography, Optical Coherence; Twins, Monozygotic; Visual Acuity | 2015 |
Fundus Autofluorescence and SD-OCT Document Rapid Progression in Autosomal Dominant Vitreoretinochoroidopathy (ADVIRC) Associated with a c.256G > A Mutation in BEST1.
Topics: Adult; Bestrophins; Carbonic Anhydrase Inhibitors; Child; Chloride Channels; Choroid Diseases; Disease Progression; Electroretinography; Eye Diseases, Hereditary; Eye Proteins; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Genes, Dominant; Humans; Macular Edema; Male; Middle Aged; Mutation, Missense; Optical Imaging; Pedigree; Polymerase Chain Reaction; Retinal Degeneration; Sequence Analysis, DNA; Sulfonamides; Thiophenes; Tomography, Optical Coherence; Visual Acuity | 2016 |
Cystoid macular lesions are resistant to topical dorzolamide treatment in enhanced S-cone syndrome child.
Topics: Administration, Topical; Carbonic Anhydrase Inhibitors; Child; Electroretinography; Eye Diseases, Hereditary; Fluorescein Angiography; Humans; Macular Edema; Male; Ophthalmic Solutions; Retina; Retinal Degeneration; Sulfonamides; Thiophenes; Tomography, Optical Coherence; Vision Disorders; Visual Acuity | 2016 |
Topical carbonic anhydrase inhibitors in macular edema associated with Alström syndrome.
Topics: Administration, Topical; Alstrom Syndrome; Carbonic Anhydrase Inhibitors; Cell Cycle Proteins; Female; Humans; Infant; Macular Edema; Ophthalmic Solutions; Proteins; Sulfonamides; Thiophenes; Tomography, Optical Coherence; Visual Acuity | 2016 |
Macular cystoid spaces in patients with retinal dystrophy.
Topics: Acetazolamide; Administration, Oral; Administration, Topical; Adolescent; Adult; Carbonic Anhydrase Inhibitors; Child; DNA Mutational Analysis; Eye Proteins; Female; Humans; Macular Edema; Male; Middle Aged; Retinal Dystrophies; Retrospective Studies; Sulfonamides; Thiophenes; Visual Acuity | 2016 |
Single-eye trial of a topical carbonic anhydrase inhibitor versus intravitreal bevacizumab for the treatment of taxane drug-induced cystoid macula oedema.
Topics: Administration, Topical; Aged; Angiogenesis Inhibitors; Bevacizumab; Bridged-Ring Compounds; Carbonic Anhydrase Inhibitors; Humans; Intravitreal Injections; Macular Edema; Male; Sulfonamides; Taxoids; Thiophenes | 2016 |
Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis.
Topics: Administration, Topical; Adolescent; Adult; Carbonic Anhydrase Inhibitors; Eye Proteins; Follow-Up Studies; Humans; Intraocular Pressure; Macular Edema; Middle Aged; Ophthalmic Solutions; Retinoschisis; Retrospective Studies; Sulfonamides; Thiophenes; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity; Young Adult | 2010 |
Diagnostic and therapeutic challenges.
Topics: Acetazolamide; Adult; Electroretinography; Fluorescein Angiography; Fundus Oculi; Humans; Macular Edema; Male; Ophthalmic Solutions; Sulfonamides; Tablets; Thiophenes; Tomography, Optical Coherence; Vision Disorders; Visual Acuity; Visual Fields | 2011 |
Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome.
Topics: Administration, Topical; Adult; Aged; Carbonic Anhydrase Inhibitors; Female; Follow-Up Studies; Humans; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Retina; Retinitis Pigmentosa; Retrospective Studies; Sulfonamides; Thiophenes; Tomography, Optical Coherence; Treatment Outcome; Usher Syndromes; Visual Acuity; Young Adult | 2010 |
Efficacy of topical dorzolamide for treatment of cystic macular lesions in a patient with enhanced S-cone syndrome.
Topics: Administration, Topical; Carbonic Anhydrase Inhibitors; Contrast Sensitivity; Humans; Macular Edema; Male; Retinal Cone Photoreceptor Cells; Retinal Diseases; Sulfonamides; Syndrome; Thiophenes; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity; Visual Field Tests; Young Adult | 2010 |
The use of carbonic anhydrase inhibitors in the retreatment of cystic macular lesions in retinitis pigmentosa and X-linked retinoschisis.
Topics: Acetazolamide; Adult; Aged; Carbonic Anhydrase Inhibitors; Female; Humans; Macular Edema; Male; Retinitis Pigmentosa; Retinoschisis; Retreatment; Retrospective Studies; Sulfonamides; Thiophenes; Tomography, Optical Coherence; Usher Syndromes; Visual Acuity | 2011 |
Topical dorzolamide for treatment of cystoid macular edema in patients with choroideremia.
Topics: Carbonic Anhydrase Inhibitors; Choroideremia; Contrast Sensitivity; Humans; Macular Edema; Male; Middle Aged; Sulfonamides; Thiophenes; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity; Visual Field Tests | 2012 |
The clinical efficacy of a topical dorzolamide in the management of cystoid macular edema in patients with retinitis pigmentosa.
Topics: Administration, Topical; Adult; Carbonic Anhydrase Inhibitors; Female; Humans; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Retina; Retinitis Pigmentosa; Sulfonamides; Thiophenes; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity; Visual Field Tests; Visual Fields; Young Adult | 2012 |
Topical dorzolamide therapy for taxane-related macular oedema.
Topics: Administration, Topical; Antihypertensive Agents; Antineoplastic Agents, Phytogenic; Female; Humans; Macular Edema; Middle Aged; Paclitaxel; Sulfonamides; Thiophenes; Treatment Outcome | 2013 |
Topical dorzolamide treatment of macular cysts in the enhanced S-cone syndrome patient.
Topics: Administration, Topical; Adult; Carbonic Anhydrase Inhibitors; Cysts; Electroretinography; Eye Diseases, Hereditary; Follow-Up Studies; Humans; Macular Edema; Male; Ophthalmic Solutions; Retinal Degeneration; Sulfonamides; Thiophenes; Tomography, Optical Coherence; Vision Disorders; Visual Acuity | 2013 |
Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa.
Topics: Administration, Topical; Carbonic Anhydrase Inhibitors; Humans; Macular Edema; Retinitis Pigmentosa; Sulfonamides; Thiophenes; Tomography, Optical Coherence; Visual Acuity | 2006 |